These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106. Intravenous ciprofloxacin for infections in cancer patients. Rolston KV; Haron E; Cunningham C; Bodey GP Am J Med; 1989 Nov; 87(5A):261S-265S. PubMed ID: 2589375 [TBL] [Abstract][Full Text] [Related]
107. Treatment of serious infections with cefotaxime utilizing an outpatient drug delivery device: global analysis of a large-scale, multicenter trial. HIAT Study Group. Poretz DM Am J Med; 1994 Aug; 97(2A):34-42. PubMed ID: 8059800 [TBL] [Abstract][Full Text] [Related]
108. Concentrations of ciprofloxacin in serum and prostatic tissue in patients undergoing transurethral resection. Grabe M; Forsgren A; Björk T Eur J Clin Microbiol; 1986 Apr; 5(2):211-2. PubMed ID: 2424755 [No Abstract] [Full Text] [Related]
110. Infections in the surgical setting: epidemiology and effect of treatment with cefotaxime in a multicenter trial including 3,032 patients. Privitera G; Auxilia F; Ortisi G; Matinato C; Castaldi S; Pagano A Am J Surg; 1992 Oct; 164(4A Suppl):6S-11S. PubMed ID: 1443361 [TBL] [Abstract][Full Text] [Related]
111. Retrospective analysis of the efficacy of cefotaxime sodium dosed twice daily. The Swedish experience. Bergquist SO; Eriksson I; Eriksson S; Lönnbro N; Runehagen A; Styrud J; Ahlquist G Diagn Microbiol Infect Dis; 1995; 22(1-2):163-6. PubMed ID: 7587033 [TBL] [Abstract][Full Text] [Related]
112. Ciprofloxacin concentrations in tonsils following single or multiple administrations. Falser N; Dalhoff A; Weuta H Infection; 1988; 16 Suppl 1():S14-8. PubMed ID: 3372028 [TBL] [Abstract][Full Text] [Related]
113. [Discontinuous oral ciprofloxacin for transurethral resection of the prostate. Initial results]. Valdevenito JP; Valdevenito R; Gómez A; Russo M Arch Esp Urol; 2006 Apr; 59(3):274-80. PubMed ID: 16724712 [TBL] [Abstract][Full Text] [Related]
114. Single-dose cefodizime as infection prophylaxis in abdominal surgery: a prospective multicenter study. Thalhammer F; Traunmüller F; Böhming HJ; Depisch D; Ilias W; Hollenstein U; Salem G; Wayand W; Burgmann H; Breyer S Infection; 1998; 26(2):136-8. PubMed ID: 9561389 [TBL] [Abstract][Full Text] [Related]
115. Prophylaxis of bacterial infections with ciprofloxacin in patients undergoing bone marrow transplantation. Lew MA; Kehoe K; Ritz J; Antman KH; Nadler L; Takvorian T; Mayer R; Kalish L; Finberg R Transplantation; 1991 Mar; 51(3):630-6. PubMed ID: 2006519 [TBL] [Abstract][Full Text] [Related]
116. Therapy of lower extremity infections with ciprofloxacin in patients with diabetes mellitus, peripheral vascular disease, or both. Peterson LR; Lissack LM; Canter K; Fasching CE; Clabots C; Gerding DN Am J Med; 1989 Jun; 86(6 Pt 2):801-8. PubMed ID: 2658581 [TBL] [Abstract][Full Text] [Related]
117. Double-blind study comparing aztreonam with placebo for prophylaxis of infection following prostatic surgery. Millar MR; Inglis T; Ewing R; Clark P; Williams RE; Lacey RW Br J Urol; 1987 Oct; 60(4):345-8. PubMed ID: 3319012 [TBL] [Abstract][Full Text] [Related]
118. Long-term follow-up after transurethral prostatic resection with or without a short peri-operative antibiotic course. Grabe M; Hellsten S Br J Urol; 1985 Aug; 57(4):444-9. PubMed ID: 3896368 [TBL] [Abstract][Full Text] [Related]
119. Ciprofloxacin and norfloxacin for selective decontamination in patients with severe granulocytopenia. Maschmeyer G; Haralambie E; Gaus W; Kern W; Dekker AW; De Vries-Hospers HG; Sizoo W; König W; Gutzler F; Daenen S Infection; 1988; 16(2):98-104. PubMed ID: 3286509 [TBL] [Abstract][Full Text] [Related]
120. Prospective, controlled, randomized, non-blind comparison of intravenous/oral ciprofloxacin with intravenous ceftazidime in the treatment of severe surgical infections. Del Rosal PL; Del Rosal LL; Riosvelasco CA; Nesbitt FC; Alanis VS Am J Med; 1989 Nov; 87(5A):183S-184S. PubMed ID: 2686420 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]